Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of CD155 for Survival and Effectiveness of Chemotherapy in Patients With Muscle Invasive Bladder Cancer

NCT03789682 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03789682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03789682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of CD155 for Survival and Effectiveness of Chemotherapy in Patients With Muscle Invasive Bladder Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
January 1, 2025
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer